FDA Inspection
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA Inspection, Jul 30, 2010
Record Details
This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on July 30, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aurobindo Pharma Limited
- Inspection Date
- July 30, 2010
- Product Type
- Drugs
View Company Profile
ID · e2ec8cd8-27f8-4bb8-a70f-248992e68a88
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 694644
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Aurobindo Pharma Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 10, 2026 | Not classified | Office of Inspections and Investigations | |
| August 4, 2023 | Not classified | Office of Inspections and Investigations | |
| May 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurobindo Pharma Limited
- FDA Inspection 1304312 - 2026-02-10
- FDA Inspection 1242351 - 2023-08-04
- FDA Inspection 1169446 - 2022-05-10
- FDA Inspection 1105823 - 2019-09-27
- FDA Inspection 1022788 - 2017-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.